Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
2021 · JAMA Neurology · 566 citations
https://doi.org/10.1001/jamaneurol.2021.3671
G
Grégory Operto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
2.8K
Citations
23
h-index
39
i10-index
Grégory Operto is an academic researcher. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Functional Brain Connectivity Studies. The author has an h-index of 23, co-authored 85 publications.
ORCID: 0000-0002-0208-1671Papers by this author
worksDifferences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
2021 · JAMA Neurology · 566 citations
https://doi.org/10.1001/jamaneurol.2021.3671
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s <i>continuum</i> when only subtle changes in Aβ pathology are detected
2020 · EMBO Molecular Medicine · 399 citations
https://doi.org/10.15252/emmm.202012921
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
2021 · Alzheimer s Research & Therapy · 65 citations
https://doi.org/10.1186/s13195-021-00878-5
Interactive effect of age and APOE-ε4 allele load on white matter myelin content in cognitively normal middle-aged subjects
2019 · NeuroImage Clinical · 40 citations
https://doi.org/10.1016/j.nicl.2019.101983
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease
2021 · Alzheimer s Research & Therapy · 24 citations
https://doi.org/10.1186/s13195-021-00781-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat